Debt-free Orchid Pharma charts out growth planOrchid Pharma, backed by Dhanuka Group, focuses on cephalosporin antibiotics. Expansion plans include a new facility, Enmetazobactam launch...
Orchid Pharma's new antibiotic 'Exblifeb' gets European Medicines Agency approvalThe Chennai-based firm said Exblifeb incorporates Enmetazobactam, "the first completely invented-in-India Beta Lactamase inhibitor" and it ...
Orchid all set to generate enough cash to fund expansion plans: Manish Dhanuka“Three years back, when we started, we had a significant debt. But, today we are a debt-free company and we also have significant investmen...